Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Marie‐Bernadette Delisle et al.|EMBO Molecular Medicine|2015Cited by 196
Somatostatin analogs: does pharmacology impact antitumor efficacy?Mounira Chalabi, Corinne Bousquet, Julie Guillermet‐Guibert et al.|Trends in Endocrinology and Metabolism|2014Cited by 97
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16Mounira Chalabi‐Dchar, Corinne Bousquet, Stéphanie Cassant‐Sourdy et al.|Gastroenterology|2015Cited by 46
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblastsSiham Moatassim-Billah, Corinne Bousquet, Camille Duluc et al.|Oncotarget|2016Cited by 39
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With MacrophagesRémi Samain, Corinne Bousquet, Alexia Brunel et al.|Cellular and Molecular Gastroenterology and Hepatology|2021Cited by 32